China Pacific Insurance
VC Fund
Shanghai, China
China Pacific Insurance is an insurance group company.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 18%
Last updated:
For AI agents: llms.txt
Industries China Pacific Insurance invests in
Stages China Pacific Insurance invests in
Countries China Pacific Insurance invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Gao Guofu
|
|||
|
Jinghui Xu
|
|||
|
Lianhong Huo
|
|||
|
Peijian Sun
|
|||
|
Xianghai Yang
|
|||
| See all 8 contacts → | |||
Investment Focus
Industry
- Health Care 7 (41%)
- Medical 6 (35%)
- Automotive 4 (24%)
- Pharmaceutical 3 (18%)
- Internet 2 (12%)
Stage
- Series C 4 (24%)
- Series D 3 (18%)
- Series A 2 (12%)
- Series B 2 (12%)
- Seed 1 (6%)
Country
- China 13 (76%)
- United States 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Gao Guofu
Chairman of the Board, Executive Director
|
Chairman of the Board, Executive Director | Total investments: 0 | Find email | |
|
Jinghui Xu
Executive Vice President
|
Executive Vice President | Total investments: 0 | Find email | |
|
Lianhong Huo
President, Executive Director
|
President, Executive Director | Total investments: 0 | Find email | |
|
Peijian Sun
Vice President
|
Vice President | Total investments: 0 | Find email | |
|
Xianghai Yang
Vice Chairman of the Board, Non-Executive Director
|
Vice Chairman of the Board, Non-Executive Director | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Zhiji Auto
|
Zhiji Automobile is a pure electric vehicle brand jointly created by SAIC Group and Alibaba Group. The company was founded in 2020 and is headquartered in Shanghai, China. | Venture - Series Unknown / Jun 19, 2024 | |
Taiyi Guanjia
|
Taiyi Guanjia is a company that combines technology and medical health innovation, aiming to enhance the insurance industry and create a robust medical and health ecosystem. | $127.3M / Seed / May 08, 2024 | |
Bang Er Orthopedic
|
Zhejiang Boner Medical Investment Management Co., Ltd. is a well-known professional hospital investment operator in the Yangtze River Delta, featuring major orthopaedics and rehabilitation. | $109.8M / Series E / Nov 09, 2023 | |
Tripod Preclinical Research Laboratories
|
Tripod is a Contract Research Organization in the biopharmaceutical space that provides preclinical research services for global pharma companies, R&D enterprises and institutes, and medical device developers. Tripod (TPR) is dedicated to nonclinical research (drug safety evaluation) for the candidates of new chemical entity (NCE), foodadditives, biologics，pesticides，veterinary drugs, and new cosmetics. | $5.5M / Series C / Apr 12, 2023 | |
Saifu Pharmaceutical
|
Saifu Pharmaceutical is a preclinical CRO service provider. | $70.9M / Series D / Dec 02, 2022 | |
Safe Medical Evaluation
|
Beijing Saifu Medical Research Institute Co., Ltd. relies on the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the National Drug Safety Evaluation and Research Center of the State of Beijing to establish strategic partnerships with them to form a combination of technology, capital and enterprise operations. The coremembers of the company are researchers of the Institute of Materia Medica of the Chinese Academy of Sciences and researchers of the Academy of Military Medical Sciences. They have high scientific research and academic status in the fields of drug research and development and toxicology research, as well as rich drug development, GLP management and technical experience, and build and operate the platform. Provides strong talent and technical support. | $71.2M / Series D / Dec 02, 2022 | |
Nest
|
Nest Bio is a manufacturer of disposable medical consumables, focusing on the R&D and production of cell culture consumables. | Series A / Jun 07, 2022 | |
Miao
|
MORE Health’s is a heath startup that aims to offer access to the best physicians in the world when they are needed the most; when patients are faced with a critical, potentially life-changing illness, such as cancer or heart disease. More health started as an incubation project under Chinese conglomerate SanPower Group. | $70.9M / Series C / Apr 02, 2019 | |
Shanghai Cell Therapy Group
|
Shanghai Cell Therapy Group is a provider of cellular diagnosis center combining cellular research and treatment services.The company is involved in cellular cold storage, cellular pharmaceuticals, antibody research, enabling patients to do genetic testing and providing research data to cancer facilities. | $131.1M / Series C / Dec 17, 2018 | |
Atzuche
|
Atzuche is a peer-to-peer car rental start-up. Founded in 2014, Atzuche operates an app, which customers can use to rent cars from car owners. After the customer orders a car, Atzuche staff will pick up the car from the owner and drive it to the customer.The platform is expanding fast. It claims to have three million registered users, and 100,000 registered cars in 14 Chinese cities, including Beijing, Shanghai and Shenzhen. Half of of its users rent cars for day trips,20% for taking test drives, and 20% for their daily commute. | $56.7M / Series C / Feb 24, 2017 | |
| See all 17 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does China Pacific Insurance invest in?
China Pacific Insurance invests primarily in Health Care, Medical and Automotive startups, most often at Series C and Series D stage. Most of the 17 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact China Pacific Insurance?
Public channels for China Pacific Insurance include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at China Pacific Insurance?
The team at China Pacific Insurance includes Gao Guofu (Chairman of the Board, Executive Director), Jinghui Xu (Executive Vice President) and Lianhong Huo (President, Executive Director), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
